346996 <common-name>11-[(5z)-5-(5-bromo-2-oxo-1-pentylindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]undecanoic acid</common-name> <description>11-[(5z)-5-(5-bromo-2-oxo-1-pentylindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]undecanoic acid is a compound with the formula C27H35BrN2O4S2. With an average molecular weight of 595.60 g/mol, 11-[(5z)-5-(5-bromo-2-oxo-1-pentylindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]undecanoic acid is a heavy molecule.</description> <cas>618076-97-4</cas> <pubchem-id>5943088</pubchem-id> <chemical-formula>C27H35BrN2O4S2</chemical-formula> <weight>595.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T10:36:11Z</created-at> <updated-at type="dateTime">2026-08-31T10:36:11Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCN1C2=C(C=C(C=C2)Br)C(=C3C(=O)N(C(=S)S3)CCCCCCCCCCC(=O)O)C1=O</moldb-smiles> <moldb-formula>C27H35BrN2O4S2</moldb-formula> <moldb-inchi>InChI=1S/C27H35BrN2O4S2/c1-2-3-11-16-29-21-15-14-19(28)18-20(21)23(25(29)33)24-26(34)30(27(35)36-24)17-12-9-7-5-4-6-8-10-13-22(31)32/h14-15,18H,2-13,16-17H2,1H3,(H,31,32)/b24-23-</moldb-inchi> <moldb-inchikey>HRBCCDYDMOTRKH-VHXPQNKSSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">594.12216</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM342889</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>11-[(5z)-5-(5-bromo-2-oxo-1-pentylindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]undecanoic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Indoles and derivatives</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0297344</sync-id> <structure-inchikey>HRBCCDYDMOTRKH-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>800040000000000000000000000000000000000000000000000002000020000000008000000004000000000000000000000000000000000000000000000000090000000000000020000010000000000000800000000200000020011000000000000000110004000400000100000000000000000000000000000040000000000002000000014044000000000000000000000000001080010100004000400000000000080000000000000028000002000000000000000000100008000000200000000100800000000000040000040000400200000000000000000000000000000040000000811600000000000010000100000000000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgcAKAAAAAMDBkAoAAAAAwQGQCgA AAADBAZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBIwAgAAAA AQYAKAAAAAMEBgAoAAAAAwQGACgAAAADBAgAKAAAAAMCBwAoAAAAAwMGACgA AAADBBAAKAAAAAMCEAAgAAAAAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYA YAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAICBgAoAAAAAwQIACgAAAADAggAaAAAAAMBAQYAKAAAAAMECAAo AAAAAwILAAEAAQIAAgMAAwQABAUABQYgBgdoDAcIaAwICWgMCQpoDAoLaAwJ DAAHDSANDigCDg8gDxAoAg8RIBESIBITKAISFAARFQAVFgAWFwAXGAAYGQAZ GgAaGwAbHAAcHQAdHgAeHwAfICgCHyEgDSIgIiMoAiIFIAsGaAwUDgBCAwAA AAUFBgcNIgYICQoLBgcFDw4UEhEXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:45:36Z</structure-indexed-at> </compound>